Neogen Corporation NEOG
13.76
0.10
0.73%
as of 25 Sep
- Market cap
- $3.0B
- P/E
- 0.0×
Follow NEOG
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Aug '25 | Nov '25 | Feb '26 | May '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(39.71%) | (25.25%) | (25.56%) | (0.38%) | |
| (26.47%) | (16.26%) | (16.46%) | (0.23%) | ||
ROIC |
(24.33%) | (14.24%) | (14.53%) | (0.50%) | |
Return on Tangible Assets |
(144.12%) | (79.31%) | (78.93%) | (1.02%) | |
Average Days of Receivables |
56.98 | 54.73 | 57.48 | 61.56 | |
Free Cash Flow per Share |
(0.01) | (0.08) | 0.03 | 0.15 | |
Free Cash Flow |
(2.54) | (17.87) | 6.30 | 32.00 | |
Capital Expenditures |
(89.51) | (84.02) | (63.10) | (51.20) | |
Piotroski F-Score |
3.00 | 4.00 | 4.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
2.85% | 2.17% | 2.27% | 2.71% | |
Accounts Receivable Turnover |
5.80 | 5.95 | 5.86 | 5.80 | |
Accounts Payable Turnover |
6.89 | 6.67 | 6.47 | 5.82 | |
Inventory Turnover |
2.43 | 2.63 | 2.60 | 2.76 | |
Average Days of Payables |
58.80 | 48.38 | 57.54 | 62.51 | |
Days of Inventory on Hand |
148.47 | 124.93 | 123.72 | 114.03 | |
Tax Rate |
(0.03) | (0.02) | (0.03) | (0.12) | |
Research and Development Expense of Revenue |
2.37% | 2.33% | 2.27% | 2.11% | |
Selling, General and Administrative Expense of Revenue |
46.28% | 46.99% | 47.30% | 47.30% | |
Share Based Compensation of Revenue |
2.06% | 2.02% | 1.69% | 1.54% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.08) | (0.11) | (0.11) | (10.53) | |
Depreciation/Fixed assets |
3.46 | 2.19 | 2.18 | 0.38 | |
Capex/Depreciation |
(0.07) | (0.12) | (0.09) | (0.41) | |
Revenue per Share |
4.08 | 4.05 | 4.00 | 4.00 | |
Operating CF per Share |
0.40 | 0.30 | 0.32 | 0.38 | |
Capex per Share |
(0.41) | (0.39) | (0.29) | (0.24) | |
Capex to Sales |
0.10 | 0.10 | 0.07 | 0.06 | |
Net Profit Margin |
(117.60%) | (68.46%) | (69.93%) | (0.91%) |
Columns are period end dates